Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Biosensors Buys China Stent Maker

publication date: Jan 10, 2008

Biosensors International Group announced plans to buy the 50% of JW Medical Systems Ltd (JW Medical) that it does not already own. Like Biosensors, JW Medical produces drug-eluting stents (DESs). JW Medical currently controls between 25% and 30% of the $400 million market in China for DESs. Biosensors will exchange 160 million shares for the 50% stake in JW Medical, making the transaction worth about $109 million. The 160 million shares that Biosensors would pay for 50% of JW Medical are about two times revenues. More details...

Stock Symbol: (SGX: B20)



Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital